215 related articles for article (PubMed ID: 18331283)
1. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study.
Sardella A; Lodi G; Demarosi F; Tarozzi M; Canegallo L; Carrassi A
J Oral Pathol Med; 2008 Aug; 37(7):395-401. PubMed ID: 18331283
[TBL] [Abstract][Full Text] [Related]
2. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
3. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
4. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
Trautmann-Sponsel RD; Dienel A
J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
[TBL] [Abstract][Full Text] [Related]
5. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum.
Usai M; Leggio B; Grappi S; Nanni G; Gambarana C; Tolu P; Giachetti D; De Montis MG
Pharmacopsychiatry; 2003 Nov; 36(6):283-7. PubMed ID: 14663651
[TBL] [Abstract][Full Text] [Related]
7. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
8. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
Agrosi M; Mischiatti S; Harrasser PC; Savio D
Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
[TBL] [Abstract][Full Text] [Related]
9. The antidepressant mechanism of Hypericum perforatum.
Mennini T; Gobbi M
Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650
[TBL] [Abstract][Full Text] [Related]
10. [Topical treatment of atopic dermatitis with Hypericum cream. A randomised, placebo-controlled, double-blind half-side comparison study].
Schempp CM; Hezel S; Simon JC
Hautarzt; 2003 Mar; 54(3):248-53. PubMed ID: 12634994
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
[TBL] [Abstract][Full Text] [Related]
12. Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin.
Cervo L; Mennini T; Rozio M; Ekalle-Soppo CB; Canetta A; Burbassi S; Guiso G; Pirona L; Riva A; Morazzoni P; Caccia S; Gobbi M
Eur Neuropsychopharmacol; 2005 Mar; 15(2):211-8. PubMed ID: 15695067
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Schellenberg R; Sauer S; Dimpfel W
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():44-53. PubMed ID: 9684947
[TBL] [Abstract][Full Text] [Related]
14. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial.
Spanemberg JC; Cherubini K; de Figueiredo MA; Gomes AP; Campos MM; Salum FG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):373-7. PubMed ID: 22669143
[TBL] [Abstract][Full Text] [Related]
15. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
16. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R
J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236
[TBL] [Abstract][Full Text] [Related]
17. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts.
Cervo L; Rozio M; Ekalle-Soppo CB; Guiso G; Morazzoni P; Caccia S
Psychopharmacology (Berl); 2002 Dec; 164(4):423-8. PubMed ID: 12457273
[TBL] [Abstract][Full Text] [Related]
18. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial.
Eatemadnia A; Ansari S; Abedi P; Najar S
Complement Ther Med; 2019 Aug; 45():109-113. PubMed ID: 31331546
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
Biber A; Fischer H; Römer A; Chatterjee SS
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
[TBL] [Abstract][Full Text] [Related]
20. [New developments in hypericum extracts: data on efficacy and interactions].
Kraft K
Wien Med Wochenschr; 2007; 157(13-14):284-7. PubMed ID: 17704973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
